T Cell Sciences, Astra negotiating collaboration on multiple sclerosis therapy.
Executive Summary
T CELL, ASTRA NEGOTIATING COLLABORATION ON MS THERAPY using "a humanized monoclonal antibody and a peptide that inhibit a specific subset of T cells related to the autoimmune disease multiple sclerosis," T Cell Sciences reports in a preliminary prospectus for a public offering. T Cell identified the compounds "in conjunction with Astra." Internal funding of the research has been halted pending outcome of the negotiations.